TotalCare SpO2RT2 bed. Product Usage: Bed, flotation therapy, powered bed may be used in a variety of settings including, but not limited to, acute care, including critical care, step down/progressive care, medical/surgical, high acuity sub-acute care, post anesthesia care unit (PACU), and sections of the emergency department (ED). The TotalCare SpO2RT® 2 Bed System is capable of being used with a broad patient population as determined appropriate by the caregiver or institution.
Published March 20, 2013 · Recall initiated: February 26, 2013
Summary
FDA records medical device Class II recall Z-0949-2013, published March 20, 2013 and initiated February 26, 2013. Recalling firm: Hill-Rom, Inc.; Status: Terminated; Reported quantity: 309; Lot: S/N between N230AM1358 & O023AM3687. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
In certain situations a software problem with the TotalCare SpO2RT® 2 bed may occur that can lead to inadvertent loss of sufficient surface cushion pressure to adequately support the patient. This may increase the likelihood of skin irritation for patients at higher risk of developing pressure-related skin conditions. A correction to the software program is currently being developed and tested,
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Hill-Rom, Inc.
- Distributor
- USA Nationwide Distribution including the state of Canada
- Lot
- S/N between N230AM1358 & O023AM3687.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAProgressa Bed, Catalog No. P7500 - Product Usage: intended to be used to treat or prevent pulmonary or otherAugust 5, 2020
- FDASteriseal-Cannula Ophthalmic; Bi-Manual Irrigating/Aspirating Handpiece.July 1, 2015
- FDAViking M, L, and XL Mobile Lifts. Non-AC-powered patient lift.June 24, 2015
- FDAAffinity® Four Birthing Bed, Product Usage: Product is intended to be used as birthing beds for women of childSeptember 10, 2014
- FDASiemens Somatom CTs equipped with software syngo CT2010A, syngo CT2010B, syngo CT2011A and CT2012B. ComputedMarch 20, 2013
- FDABrilliance 64 and Ingenuity Computed Tomography X-Ray Systems The Brilliance 64 and Ingenuity CT are wholeMarch 20, 2013
Questions about this recall
Was TotalCare SpO2RT2 bed. Product Usage: Bed, flotation therapy, powered bed may be used in a variety of settings including, but not limited to, acute care, including critical care, step down/progressive care, medical/surgical, high acuity sub-acute care, post anesthesia care unit (PACU), and sections of the emergency department (ED). The TotalCare SpO2RT® 2 Bed System is capable of being used with a broad patient population as determined appropriate by the caregiver or institution. recalled?
Yes. FDA published recall Z-0949-2013 on March 20, 2013. Reported hazard: In certain situations a software problem with the TotalCare SpO2RT® 2 bed may occur that can lead to inadvertent loss of sufficient surface cushion pressure to adequately support the patient. This may increase the likelihood of skin irritation for patients at higher risk of developing pressure-related skin conditions. A correction to the software program is currently being developed and tested,
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit